Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 1
2006 2
2007 2
2010 2
2011 3
2012 1
2013 3
2014 5
2015 3
2016 3
2017 2
2018 10
2019 13
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury.
Sangiovanni E, Fumagalli M, Pacchetti B, Piazza S, Magnavacca A, Khalilpour S, Melzi G, Martinelli G, Dell'Agli M. Sangiovanni E, et al. Phytother Res. 2019 Aug;33(8):2083-2093. doi: 10.1002/ptr.6400. Epub 2019 Jun 27. Phytother Res. 2019. PMID: 31250491 Free article.
Skin inflammatory diseases result from complex events that include dysregulation and abnormal expression of inflammatory mediators or their receptors in skin cells. ...Our findings provide new insights into the potential effect of Cannabis extracts against in
Skin inflammatory diseases result from complex events that include dysregulation and abnormal expression of inflammatory media
The potential role of cannabinoids in dermatology.
Sheriff T, Lin MJ, Dubin D, Khorasani H. Sheriff T, et al. J Dermatolog Treat. 2019 Oct 10:1-7. doi: 10.1080/09546634.2019.1675854. Online ahead of print. J Dermatolog Treat. 2019. PMID: 31599175
Cannabis is increasingly being used world-wide to treat a variety of dermatological conditions. Medicinal cannabis is currently legalized in Canada, 31 states in America and 19 countries in Europe. The authors reviewed the literature on the pharmacology and use of cannabin …
Cannabis is increasingly being used world-wide to treat a variety of dermatological conditions. Medicinal cannabis is currently legal …
A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars.
Palmieri B, Laurino C, Vadalà M. Palmieri B, et al. Clin Ter. 2019 Mar-Apr;170(2):e93-e99. doi: 10.7417/CT.2019.2116. Clin Ter. 2019. PMID: 30993303 Free article.
OBJECTIVE: To investigate the therapeutic effect of CBD-ointment administered on severe skin chronic diseases and/or on their outcome scars. ...The subjects were instructed to administer topical CBD-enriched ointment to lesioned skin areas twice daily for thr …
OBJECTIVE: To investigate the therapeutic effect of CBD-ointment administered on severe skin chronic diseases and/or on their …
The growing trend of cannabidiol in skincare products.
Jhawar N, Schoenberg E, Wang JV, Saedi N. Jhawar N, et al. Clin Dermatol. 2019 May-Jun;37(3):279-281. doi: 10.1016/j.clindermatol.2018.11.002. Epub 2018 Nov 29. Clin Dermatol. 2019. PMID: 31178109
Recently, cannabidiol has garnered considerable attention in the public and media as a trendy and popular ingredient in skincare products. ...Others claim it to be a cure for skin aging, acne, eczema, psoriasis, and pruritus. However, current data is limited regardi …
Recently, cannabidiol has garnered considerable attention in the public and media as a trendy and popular ingredient in skincare prod …
Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.
Chelliah MP, Zinn Z, Khuu P, Teng JMC. Chelliah MP, et al. Pediatr Dermatol. 2018 Jul;35(4):e224-e227. doi: 10.1111/pde.13545. Epub 2018 May 22. Pediatr Dermatol. 2018. PMID: 29786144
Epidermolysis bullosa is a rare blistering skin disorder that is challenging to manage because skin fragility and repeated wound healing cause itching, pain, limited mobility, and recurrent infections. Cannabidiol, an active cannabinoid found in cannabis, is …
Epidermolysis bullosa is a rare blistering skin disorder that is challenging to manage because skin fragility and repeated wou …
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.
Oláh A, Tóth BI, Borbíró I, Sugawara K, Szöllõsi AG, Czifra G, Pál B, Ambrus L, Kloepper J, Camera E, Ludovici M, Picardo M, Voets T, Zouboulis CC, Paus R, Bíró T. Oláh A, et al. J Clin Invest. 2014 Sep;124(9):3713-24. doi: 10.1172/JCI64628. Epub 2014 Jul 25. J Clin Invest. 2014. PMID: 25061872 Free PMC article.
Here, we explored the effects of the major nonpsychotropic phytocannabinoid of Cannabis sativa, (-)-cannabidiol (CBD), on human sebaceous gland function and determined that CBD behaves as a highly effective sebostatic agent. Administration of CBD to cultured human sebocyte …
Here, we explored the effects of the major nonpsychotropic phytocannabinoid of Cannabis sativa, (-)-cannabidiol (CBD), on human sebac …
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB(2) receptor-dependent pathways.
Del Rio C, Cantarero I, Palomares B, Gómez-Cañas M, Fernández-Ruiz J, Pavicic C, García-Martín A, Luz Bellido M, Ortega-Castro R, Pérez-Sánchez C, López-Pedrera C, Appendino G, Calzado MA, Muñoz E. Del Rio C, et al. Br J Pharmacol. 2018 Oct;175(19):3813-3831. doi: 10.1111/bph.14450. Epub 2018 Aug 23. Br J Pharmacol. 2018. PMID: 30033591 Free PMC article.
BACKGROUND AND PURPOSE: The endocannabinoid system and PPARγ are important targets for the development of novel compounds against fibrotic diseases such as systemic sclerosis (SSc), also called scleroderma. The aim of this study was to characterize VCE-004.3, a novel ca
BACKGROUND AND PURPOSE: The endocannabinoid system and PPARγ are important targets for the development of novel compounds against fibrotic …
EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.
García-Martín A, Garrido-Rodríguez M, Navarrete C, Del Río C, Bellido ML, Appendino G, Calzado MA, Muñoz E. García-Martín A, et al. Biochem Pharmacol. 2018 Nov;157:304-313. doi: 10.1016/j.bcp.2018.07.047. Epub 2018 Aug 2. Biochem Pharmacol. 2018. PMID: 30076848
EHP-101 could also prevent the reduced expression of vascular CD31 typical of skin fibrosis. RNAseq analysis of skin biopsies showed a clear effect of EHP-101 in the inflammatory and epithelial-mesenchymal transition transcriptomic signatures. ...Taken together, the …
EHP-101 could also prevent the reduced expression of vascular CD31 typical of skin fibrosis. RNAseq analysis of skin biopsies …
Future Aspects for Cannabinoids in Breast Cancer Therapy.
Kisková T, Mungenast F, Suváková M, Jäger W, Thalhammer T. Kisková T, et al. Int J Mol Sci. 2019 Apr 3;20(7):1673. doi: 10.3390/ijms20071673. Int J Mol Sci. 2019. PMID: 30987191 Free PMC article. Review.
Indeed, the psychoactive delta-9-tetrahydrocannabinol (THC), non-psychoactive cannabidiol (CBD) and other CBs inhibited disease progression in breast cancer models. ...
Indeed, the psychoactive delta-9-tetrahydrocannabinol (THC), non-psychoactive cannabidiol (CBD) and other CBs inhibited disease progr …
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Bergamaschi MM, et al. Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol (CBD), one major non-psychotomimetic compound of the cannabis sativa plant, has shown anxiolytic effects both in humans and in animals. …
Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol
46 results
Jump to page
Feedback